The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
24 Sep 2021
Historique:
received: 23 07 2021
revised: 14 09 2021
accepted: 17 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 19 11 2021
Statut: epublish

Résumé

Carotenoids and docosahexaenoic acid (DHA) were identified as essential components for eye health and are both naturally present in eggs. We aimed to evaluate the effect of the daily consumption of two eggs enriched with lutein/zeaxanthin and DHA on macular pigment optical density (MPOD) and on circulating xanthophyll and fatty acid concentrations in healthy participants. Ninety-nine healthy volunteers consumed either two standard eggs or two enriched eggs per day for 4 months. MPOD was measured at baseline (V0) and at follow-up (V4) using a modified confocal scanning laser ophthalmoscope (primary outcome). Blood samples were collected to determine total plasma and lipoprotein fatty acids and lutein/zeaxanthin compositions at V0 and V4 (secondary outcomes). A slight but significant increase in MPOD was observed for all study participants consuming two eggs per day for 4 months at all eccentricities (0.5°, 1°, 2°, and 4°). Plasma and lipoprotein lutein, zeaxanthin, and DHA concentrations significantly increased in both groups but were greater in the enriched group (for the enriched group (V0 vs. V4): lutein, 167 vs. 369 ng/mL; zeaxanthin, 17.7 vs. 29.2 ng/mL; DHA, 1.89 vs. 2.56% of total fatty acids). Interestingly, lutein from high-density lipoprotein (HDL) was strongly correlated with MPOD at 0.5 and 1° eccentricities (rho = 0.385, MPOD was slightly increased in both groups. Lutein, zeaxanthin, and DHA plasma concentrations were strongly enhanced in the enriched group compared with the standard group. A significant correlation was found between MPOD level and lutein concentration in HDL.

Sections du résumé

BACKGROUND BACKGROUND
Carotenoids and docosahexaenoic acid (DHA) were identified as essential components for eye health and are both naturally present in eggs.
OBJECTIVE OBJECTIVE
We aimed to evaluate the effect of the daily consumption of two eggs enriched with lutein/zeaxanthin and DHA on macular pigment optical density (MPOD) and on circulating xanthophyll and fatty acid concentrations in healthy participants.
METHODS METHODS
Ninety-nine healthy volunteers consumed either two standard eggs or two enriched eggs per day for 4 months. MPOD was measured at baseline (V0) and at follow-up (V4) using a modified confocal scanning laser ophthalmoscope (primary outcome). Blood samples were collected to determine total plasma and lipoprotein fatty acids and lutein/zeaxanthin compositions at V0 and V4 (secondary outcomes).
RESULTS RESULTS
A slight but significant increase in MPOD was observed for all study participants consuming two eggs per day for 4 months at all eccentricities (0.5°, 1°, 2°, and 4°). Plasma and lipoprotein lutein, zeaxanthin, and DHA concentrations significantly increased in both groups but were greater in the enriched group (for the enriched group (V0 vs. V4): lutein, 167 vs. 369 ng/mL; zeaxanthin, 17.7 vs. 29.2 ng/mL; DHA, 1.89 vs. 2.56% of total fatty acids). Interestingly, lutein from high-density lipoprotein (HDL) was strongly correlated with MPOD at 0.5 and 1° eccentricities (rho = 0.385,
CONCLUSIONS CONCLUSIONS
MPOD was slightly increased in both groups. Lutein, zeaxanthin, and DHA plasma concentrations were strongly enhanced in the enriched group compared with the standard group. A significant correlation was found between MPOD level and lutein concentration in HDL.

Identifiants

pubmed: 34684356
pii: nu13103347
doi: 10.3390/nu13103347
pmc: PMC8541434
pii:
doi:

Substances chimiques

Lipoproteins 0
Macular Pigment 0
Xanthophylls 0
Zeaxanthins 0
Docosahexaenoic Acids 25167-62-8
Lutein X72A60C9MT

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Bpifrance
ID : not available

Références

PLoS One. 2015 Oct 09;10(10):e0139257
pubmed: 26451726
Ups J Med Sci. 2008;113(3):315-23
pubmed: 18991244
Graefes Arch Clin Exp Ophthalmol. 2003 Aug;241(8):647-51
pubmed: 12883916
J Opt Soc Am A Opt Image Sci Vis. 1997 Jun;14(6):1187-96
pubmed: 9168592
Acta Ophthalmol. 2017 Dec;95(8):e763-e769
pubmed: 28271618
Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):199-204
pubmed: 19545988
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):3976-82
pubmed: 17724175
Arch Ophthalmol. 2006 Jul;124(7):1038-45
pubmed: 16832030
Eur J Clin Nutr. 2007 Nov;61(11):1341-4
pubmed: 17299457
Ophthalmology. 2013 Aug;120(8):1619-31
pubmed: 23395546
Prostaglandins Leukot Essent Fatty Acids. 2013 Jul;89(1):1-8
pubmed: 23676322
J Lipid Res. 1964 Oct;5:600-8
pubmed: 14221106
Am J Clin Nutr. 2009 Nov;90(5):1272-9
pubmed: 19759170
J Lipid Res. 2016 Oct;57(10):1865-1878
pubmed: 27538825
Nutrition. 2013 Oct;29(10):1237-44
pubmed: 23911216
Lipids. 1996 Jan;31(1):65-70
pubmed: 8649236
Am J Clin Nutr. 2015 Jul;102(1):75-83
pubmed: 26016861
Prog Retin Eye Res. 2016 Jan;50:34-66
pubmed: 26541886
Arch Biochem Biophys. 2001 Jul 15;391(2):160-4
pubmed: 11437346
Exp Eye Res. 2013 Nov;116:190-8
pubmed: 24007642
Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2243-57
pubmed: 8843911
Nutr J. 2014 Jun 03;13:52
pubmed: 24889185
Am J Clin Nutr. 2008 May;87(5):1521-9
pubmed: 18469279
J Chromatogr B Biomed Sci Appl. 2001 Feb 25;751(2):297-303
pubmed: 11236085
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2329-35
pubmed: 16723441
Prog Retin Eye Res. 2004 Sep;23(5):533-59
pubmed: 15302350
Nutr Metab Cardiovasc Dis. 2014 Feb;24(2):155-61
pubmed: 24418384
JAMA Ophthalmol. 2017 Nov 1;135(11):1259-1266
pubmed: 28973076
Am J Clin Nutr. 2007 Mar;85(3):762-9
pubmed: 17344498
Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6178-86
pubmed: 22879423
Lipids. 2004 Jun;39(6):527-35
pubmed: 15554151
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4866-81; biography 4864-5
pubmed: 17962433
J Nutr. 1989 Dec;119(12):1880-92
pubmed: 2576038
Clin Ophthalmol. 2016 Oct 31;10:2149-2155
pubmed: 27826180
Am J Clin Nutr. 2000 Jan;71(1 Suppl):232S-7S
pubmed: 10617977
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):709-14
pubmed: 16431971
JAMA. 2013 May 15;309(19):2005-15
pubmed: 23644932
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
Food Funct. 2013 Feb;4(2):213-21
pubmed: 23128450
Am J Clin Nutr. 2008 Aug;88(2):398-406
pubmed: 18689376
Nutrients. 2013 Feb 15;5(2):543-51
pubmed: 23434908
J Clin Invest. 1955 Sep;34(9):1345-53
pubmed: 13252080
Nutrients. 2020 May 06;12(5):
pubmed: 32384663
Br J Nutr. 2006 Nov;96(5):921-8
pubmed: 17092383
Prog Retin Eye Res. 2012 Jul;31(4):303-15
pubmed: 22465791
Clin Chim Acta. 1981 Jul 18;114(1):111-6
pubmed: 7249369
Arch Biochem Biophys. 2010 Dec 1;504(1):50-5
pubmed: 20599660
Arch Ophthalmol. 2006 Aug;124(8):1151-62
pubmed: 16908818
Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):666-71
pubmed: 12192461
Prog Lipid Res. 1983;22(2):79-131
pubmed: 6348799
Eur J Nutr. 2013 Jun;52(4):1381-91
pubmed: 23052623
Minn Med. 1969 Aug;52(8):1225-30
pubmed: 5804989
J Nutr. 2004 Aug;134(8):1887-93
pubmed: 15284371
Am J Clin Nutr. 2012 Apr;95(4):966-71
pubmed: 22357725
J Opt Soc Am A Opt Image Sci Vis. 2001 Jun;18(6):1212-30
pubmed: 11393613
Invest Ophthalmol Vis Sci. 2011 Jun 06;52(7):3934-42
pubmed: 21245404
Invest Ophthalmol Vis Sci. 2014 May 02;55(5):2941-6
pubmed: 24576878
J Am Coll Nutr. 2016 Nov-Dec;35(8):704-716
pubmed: 27710205
JAMA Ophthalmol. 2014 Feb;132(2):142-9
pubmed: 24310343
Lipids. 1996 Mar;31 Suppl:S193-7
pubmed: 8729118
Nutrients. 2016 Jul 12;8(7):
pubmed: 27420092
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1086-91
pubmed: 19797209
Am J Clin Nutr. 2009 Dec;90(6):1601-7
pubmed: 19812176
Nutr J. 2015 Oct 07;14:104
pubmed: 26445881
Ophthalmology. 2008 Feb;115(2):334-41
pubmed: 17664009
Am J Cardiol. 2006 Aug 21;98(4A):39i-49i
pubmed: 16919516
Br J Nutr. 2017 Jan;117(1):108-123
pubmed: 28122649
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2711-23
pubmed: 23695657
Nutr Res Rev. 2007 Dec;20(2):163-79
pubmed: 19079868

Auteurs

Coralie Schnebelen-Berthier (C)

Service Nutrition & Activité Physique, Institut Pasteur de Lille, F-59019 Lille, France.

Niyazi Acar (N)

Centre des Sciences du Goût et de l'Alimentation, Agrosup Dijon, CNRS, INRA, Université Bourgogne Franche-Comté, F-21000 Dijon, France.

Emilie Simon (E)

Service Nutrition & Activité Physique, Institut Pasteur de Lille, F-59019 Lille, France.

Clémentine Thabuis (C)

ROQUETTE, F-62080 Lestrem, France.

Anne Bourdillon (A)

MIXSCIENCE, Centre d'Affaires Odyssée, ZAC Cicé Blossac, F-35172 Bruz, France.

Adeline Mathiaud (A)

MIXSCIENCE, Centre d'Affaires Odyssée, ZAC Cicé Blossac, F-35172 Bruz, France.

Luc Dauchet (L)

CNRS, INSERM, CHU de Lille, Institut Pasteur de Lille, UMR 1283-EGID, "Integrative Genomics and Modelling of Metabolic Diseases", Université de Lille, F-59045 Lille, France.

Cécile Delcourt (C)

"Bordeaux Population Health Research Center" (BPH), INSERM, UMR1219, "Lifelong Exposures, Health and Ageing" (LEHA) Group, Université de Bordeaux, F-33076 Bordeaux, France.

Pascale Benlian (P)

CNRS, INSERM, CHU de Lille, Institut Pasteur de Lille, UMR 1283-EGID, "Integrative Genomics and Modelling of Metabolic Diseases", Université de Lille, F-59045 Lille, France.

Martine Crochet (M)

CHU Lille, Service d'Exploration de la Vision et Neuro-Ophtalmologie, F-59000 Lille, France.

Sabine Defoort (S)

CHU Lille, Service d'Exploration de la Vision et Neuro-Ophtalmologie, F-59000 Lille, France.

Anne Tailleux (A)

CNRS, INSERM, CHU de Lille, Institut Pasteur de Lille, UMR 1283-EGID, "Integrative Genomics and Modelling of Metabolic Diseases", Université de Lille, F-59045 Lille, France.

Bart Staels (B)

CNRS, INSERM, CHU de Lille, Institut Pasteur de Lille, UMR 1283-EGID, "Integrative Genomics and Modelling of Metabolic Diseases", Université de Lille, F-59045 Lille, France.

Lionel Bretillon (L)

Centre des Sciences du Goût et de l'Alimentation, Agrosup Dijon, CNRS, INRA, Université Bourgogne Franche-Comté, F-21000 Dijon, France.

Jean-Michel Lecerf (JM)

Service Nutrition & Activité Physique, Institut Pasteur de Lille, F-59019 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH